Gulf Pharmaceutical Industries, known as Julphar, has been announced as the main partner for the Global Manufacturing – Pharmaceuticals segment of the 14th AIM Investment Summit 2025. This partnership was revealed by the AIM Investment Summit organizers in Abu Dhabi on March 19.

Julphar’s involvement signifies a commitment to enhancing the pharmaceutical manufacturing sector on a global scale. The summit aims to bring together industry leaders and stakeholders to discuss advancements and opportunities in investment and manufacturing.

The AIM Investment Summit is a significant event in the investment landscape, and Julphar’s role as a main partner will likely highlight innovations and developments in the pharmaceutical field. By collaborating in this summit, Julphar is positioned to play a critical role in shaping the future of healthcare investments and manufacturing practices.